为2型糖尿病成年患者开发和评估DiabetesXcel移动应用程序
Ashley A Berlot1, Phillip S Chen1, Savneet Kaur2
1Albert Einstein College of Medicine, Bronx, NY.
概括
一个移动应用程序改善了纽约布朗克斯成年人的2型糖尿病管理. 参与者表现出更好的生活质量,自我管理,以及像A1C这样的健康标志物,医院访问较少.
科学领域:
- 数字健康干预措施 数字健康干预措施
- 糖尿病管理技术 糖尿病管理技术
- 城市环境中的公共卫生
背景情况:
- 2型糖尿病是一种常见的慢性疾病,具有显著的并发症.
- 像纽约布朗克斯这样的城市地区面临着高糖尿病患病率.
- 有效的自我管理工具对于改善患者的结果至关重要.
研究的目的:
- 为了评估一个移动应用程序DiabetesXcel的有效性,用于管理2型糖尿病.
- 评估DiabetesXcel对患者报告结果和临床标志物的影响.
- 确定干预对医疗保健利用的影响.
主要方法:
- 一项涉及50名患有2型糖尿病的成年人的试验在纽约布朗克斯.
- 使用了一个移动应用程序 (DiabetesXcel),包含教育视频和模块.
- 在基线,4个月和6个月收集的数据.
主要成果:
- 在生活质量,自我管理,知识,自我效能和抑郁症方面观察到显著的改善.
- 在A1C和LDL胆固醇水平的显著降低.
- 与糖尿病相关的急诊室访问和住院病例显著减少6个月.
结论:
- 糖尿病Xcel移动应用程序显示承诺作为一种有益的工具,用于2型糖尿病自我管理.
- 数字健康干预措施可以积极影响临床结果,并减少高风险人群的医疗保健利用率.
- 进一步的研究可能会探索在糖尿病护理中更广泛地实施这种应用.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
526
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
526
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Management and Pharmacotherapy
268
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
268
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Insulin: Dosing Regimen and Adverse Effects
168
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
168


